Tuesday, March 28, 2023

Latest:

Debating Diets: What is the pescatarian diet?
Researchers pave the way for solutions to problems affecting preterm infants
Growing Up Baylor – DeBakey High School Edition: Dr. Lynda Chima Aririguzo
6 tips to prevent colon cancer
TRISH to study how the human body and mind respond to spaceflight

Baylor College of Medicine Blog Network

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

steroid receptor coactivator

From The Labs

USP15 could be a target in ovarian cancer scientists have been looking for

May 8, 2018May 8, 2018lysosome, ovarian cancer, ovarian steroids, p53, p53-R175H, proteasome, Research, steroid receptor coactivator, USP 15

Ovarian cancer is currently treated with surgery and chemotherapy. Chemotherapy for ovarian cancer is based on drugs that act on any cell that is rapidly

From The Labs

New class of small molecule, SI-2, can drug the ‘undruggable’ steroid receptor coactivator-3

June 16, 2016Cancer, drugs, SI-2, SRC-3, steroid receptor, steroid receptor coactivator

By Ana María Rodríguez, Ph.D. Steroid receptor coactivator-3, which is well-known for its role in cancer formation and proliferation, is usually considered ‘undruggable’ because this nuclear

From the Labs: a transparent heart